Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02466659 · ClinicalTrials.gov registry record · NA
Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02466659 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 8 participants.
The verdict
NCT02466659, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old.
Interventions
- DEVICE CIAO therapy Amblyz glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-02-01 |
| Est. Completion | 2016-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02466659
The ClinicalTrials.gov registry entry for NCT02466659 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CIAO therapy Amblyz glasses is the first listed.
NCT02466659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02466659 about?
NCT02466659 is a clinical study titled "Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia". To determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old.
What is the current status of trial NCT02466659?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2015-02-01. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT02466659?
The interventions under investigation include: CIAO therapy Amblyz glasses (DEVICE).
Who is sponsoring clinical trial NCT02466659?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.